From vibrators to penis size to squirting, these are the topics sex educators say people secretly want to know more about.

Cancer screening tests can be divided into early detection and preventive tests. 1 Early-detection tests (eg, mammography for breast cancer and prostate-specific antigen testing for prostate cancer) ...

The new prostate cancer spit test reduced the number of false positive results and picked up a higher proportion of ...

TRANSPERINEAL (TP) prostate biopsy is a promising alternative to the traditional transrectal (TR) biopsy for prostate cancer (PCa) diagnosis. As PCa detection remains a challenge, the ability of these ...

Rarely, they are indicative of serious causes such as colon or rectal cancer. There are many reasons for thin or narrow stools ... They will use a well-lubricated, gloved hand to insert a finger or ...

Huntsman Cancer Institute’s Urologic Cancers Program provides comprehensive, compassionate, state-of-the-art care for people with these cancers. Our experts treat and diagnose all types of urologic ...

March marks Colon Cancer Awareness Month, and health professionals across the country are encouraging people to take action. Their message is simple: get screened early—because it can save your life. ...

AN MSP has described NHS Ayrshire and Arran waiting times for prostate cancer treatment as a "timebomb". The 62-day standard states that 95 per cent of eligible patients should wait no longer than 62 ...

“I think we now have really robust data showing that earlier treatment intensification with combination regimens does lead to improved survival for patients with metastatic hormone-sensitive prostate ...

After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, opening up the radioligand therapy to a much broader prostate cancer population. The new approval, which triples ...

The King announced his cancer diagnosis following a three-day hospital stay following a prostate procedure on February 6, 2024. (The palace did clarify that the King does not have prostate cancer.) ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for trofolastat (RoTecPSMA), a prostate-specific membrane antigen (PSMA)-targeting agent for detecting ...